📰 Risk Evaluation News
Page 47 - Risk Evaluation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Risk Evaluation. Real-time updates on events, politics, business and more.
January 27, 2023
27.01.2023 - Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, announced today that CARTITUDE-4, the Phase 3 study ...
January 26, 2023
A company that makes an abortion pill filed a lawsuit Wednesday morning challenging the constitutionality of a state ban on the medication, one in what is expected to be a wave of cases arguing that the federal Food and Drug Administrations approval of the pill takes precedence over such restrictive state laws.
January 25, 2023
The case, brought by GenBioPro, a company that makes one of two abortion drugs, argues that it is unconstitutional for a state to bar access to a medication approved by the federal government.
January 25, 2023
Ketamine therapy is a revolutionary new depression treatment. But as multimillion-dollar investments pour in, some people find they can't stop.
January 24, 2023
The Food and Drug Administration (the “FDA”) has approved a modification to the Mifepristone Risk Evaluation and Mitigation Strategy (“REMS”) Program, increasing the accessibility of...
January 24, 2023
Americans should demand answers as to why Joe Biden and the FDA are making the abortion pill riskier for women.
January 21, 2023
The FDA approved a modification to the Mifepristone Risk Evaluation and Mitigation Strategy, REMS, Program. The FDA’s approval of commercial dispensing of mifepristone likely will not change the current practice of prescribing and dispensing mifepristone for abortion.
January 19, 2023
On January 3, 2023, FDA released an updated Risk Evaluation and Mitigation Strategy (REMS) for mifepristone. The updated REMS follows a December 2021 FDA announcement that it would...
January 18, 2023
Florida has told pharmacies they may not dispense the abortion pill after the U.S. Food and Drug Administration said it would allow women to obtain chemical abortion drugs over the counter.
January 18, 2023
On January 3, the Biden Administration took additional steps to ease access to FDA-approved abortion medication in the United States, further wading into the legal and political chaos that has sprung up ...